Cardiocentro Ticino

Lugano CH-6900

0 studies enrolling now · 11 studies all time

What they study most

Atrial Fibrillation, CIED Related Infection, Cardiovascular Disease, Congestive Heart Failure, Heart Failure, Hemorrhage, Invasive Procedure, Low Cardiac Output, Out-of-hospital Cardiac Arrest, Prevention of Stroke or Systemic Embolism, Tachyarrhythmias, Urgent Surgery

Studies at this site

• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Bentracimab in Ticagrelor-treated Patients With Uncontrolled Bleeding or Requiring Urgent Surgery or Invasive Procedure — Completed
• Targeted Hypothermia Versus Targeted Normothermia After Out-of-hospital Cardiac Arrest — Completed
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) — Completed
• World-wide Randomized Antibiotic Envelope Infection Prevention Trial — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Clinical Performance of the Protecta ICD and CRT-D — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed